RNAi therapeutics for treatment of eye neovascularization diseases

Details for Australian Patent Application No. 2005213484 (hide)

International Classifications

Event Publications

9 August 2007 Section 223 Application Received

Intradigm Corporation An application to extend the time from 05 Sep 2006 to 05 May 2007 in which to enter the National Phase has been filed . Address for service in Australia - Davies Collison Cave Level 3, 303 Coronation Drive Milton Business Centre Milton QLD 4064

4 October 2007 Section 223 Application Allowed

Intradigm Corporation The time in which to enter the national phase has been extended to 05 May 2007. Address for service in Australia - Davies Collison Cave Level 3 303 Coronation Drive Milton QLD 4064

11 October 2007 PCT application entered the National Phase

PCT publication WO2005/076998 Priority application(s): WO2005/076998

1 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.